Patents by Inventor CHRISTOPHE DESTERKE

CHRISTOPHE DESTERKE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods and compositions for treating cancers
    Patent number: 12403110
    Abstract: The inventors provide a new therapeutic strategy to treat cancers expressing embryonic antigens. Accordingly, the present invention relates to a method of treating a subject suffering from a cancer comprising a step of administration simultaneously, separately or sequentially to said subject a therapeutically amount of i) a population of derived engineered fetal stem cells carrying cancer associated fetal neo-antigen and ii) a compound selected from a group which activates immune response, as a combined preparation.
    Type: Grant
    Filed: June 9, 2023
    Date of Patent: September 2, 2025
    Assignees: INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE (INSERM), ASSISTANCE PUBLIQUE-HÔPITAUX DE PARIS, UNIVERSITÉ PARIS-SACLAY, UNIVERSITÉ PARIS CITÉ
    Inventors: Frank Griscelli, Ali Turhan, Annelise Bennaceur Griscelli, Christophe Desterke
  • METHODS AND COMPOSITIONS FOR TREATING CANCERS
    Publication number: 20230338494
    Abstract: The inventors provide a new therapeutic strategy to treat cancers expressing embryonic antigens. Accordingly, the present invention relates to a method of treating a subject suffering from a cancer comprising a step of administration simultaneously, separately or sequentially to said subject a therapeutically amount of i) a population of derived engineered fetal stem cells carrying cancer associated fetal neo-antigen and ii) a compound selected from a group which activates immune response, as a combined preparation.
    Type: Application
    Filed: June 9, 2023
    Publication date: October 26, 2023
    Inventors: Frank GRISCELLI, Ali TURHAN, Annelise BENNACEUR GRISCELLI, Christophe DESTERKE
  • Methods and compositions for treating cancers
    Patent number: 11679148
    Abstract: The inventors provide a new therapeutic strategy to treat cancers expressing embryonic antigens. Accordingly, the present invention relates to a method of treating a subject suffering from a cancer comprising a step of administration simultaneously, separately or sequentially to said subject a therapeutically amount of i) a population of derived engineered fetal stem cells carrying cancer associated fetal neo-antigen and ii) a compound selected from a group which activates immune response, as a combined preparation.
    Type: Grant
    Filed: November 23, 2018
    Date of Patent: June 20, 2023
    Assignees: INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE (INSERM), ASSISTANCE PUBLIQUE—HÔPITAUX DE PARIS, UNIVERSITÉ PARIS-SACLAY, UNIVERSITÉ PARIS CITÉ
    Inventors: Frank Griscelli, Ali Turhan, Annelise Bennaceur Griscelli, Christophe Desterke
  • METHODS AND COMPOSITIONS FOR TREATING CANCERS
    Publication number: 20210030855
    Abstract: The inventors provide a new therapeutic strategy to treat cancers expressing embryonic antigens. Accordingly, the present invention relates to a method of treating a subject suffering from a cancer comprising a step of administration simultaneously, separately or sequentially to said subject a therapeutically amount of i) a population of derived engineered fetal stem cells carrying cancer associated fetal neo-antigen and ii) a compound selected from a group which activates immune response, as a combined preparation.
    Type: Application
    Filed: November 23, 2018
    Publication date: February 4, 2021
    Inventors: Frank GRISCELLI, Ali TURHAN, Annelise BENNACEUR GRISCELLI, Christophe DESTERKE
  • METHODS OF IMPROVING HEMATOPOIETIC GRAFTS
    Publication number: 20200080058
    Abstract: The present invention relates to a method of preparing hematopoietic cell graft or enriching a population of cells for hematopoietic stem cells that are capable of long-term multilineage engraftment and self-renewal. It also relates to hematopoietic grafts comprising said hematopoietic stem cells as well as their uses in therapy.
    Type: Application
    Filed: March 21, 2018
    Publication date: March 12, 2020
    Inventors: LAURENCE GUYONNEAU-HARMAND, CHRISTOPHE DESTERKE, THIERRY JAFFREDO, ALAIN CHAPEL, LOÏC GARCON, LUC DOUAY